Statin-associated autoimmune myopathy. 2017

Tasneam Shagroni, and Chantel Park, and Emilie Rouah, and Onome Whiteru
Department of Medicine.

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D008297 Male Males
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D018908 Muscle Weakness A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251) Muscular Weakness,Muscle Weaknesses,Muscular Weaknesses,Weakness, Muscle,Weakness, Muscular,Weaknesses, Muscle,Weaknesses, Muscular
D019161 Hydroxymethylglutaryl-CoA Reductase Inhibitors Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. HMG-CoA Reductase Inhibitor,HMG-CoA Reductase Inhibitors,Hydroxymethylglutaryl-CoA Reductase Inhibitor,Statin,Statins, HMG-CoA,Inhibitors, HMG-CoA Reductase,Inhibitors, Hydroxymethylglutaryl-CoA,Inhibitors, Hydroxymethylglutaryl-Coenzyme A,Statins,HMG CoA Reductase Inhibitor,HMG CoA Reductase Inhibitors,HMG-CoA Statins,Hydroxymethylglutaryl CoA Reductase Inhibitor,Hydroxymethylglutaryl CoA Reductase Inhibitors,Hydroxymethylglutaryl-CoA Inhibitors,Hydroxymethylglutaryl-Coenzyme A Inhibitors,Inhibitors, HMG CoA Reductase,Inhibitors, Hydroxymethylglutaryl CoA,Inhibitors, Hydroxymethylglutaryl Coenzyme A,Inhibitors, Hydroxymethylglutaryl-CoA Reductase,Reductase Inhibitor, Hydroxymethylglutaryl-CoA,Reductase Inhibitors, HMG-CoA,Reductase Inhibitors, Hydroxymethylglutaryl-CoA,Statins, HMG CoA

Related Publications

Tasneam Shagroni, and Chantel Park, and Emilie Rouah, and Onome Whiteru
February 2016, The New England journal of medicine,
Tasneam Shagroni, and Chantel Park, and Emilie Rouah, and Onome Whiteru
September 2014, Modern rheumatology,
Tasneam Shagroni, and Chantel Park, and Emilie Rouah, and Onome Whiteru
December 2014, Cleveland Clinic journal of medicine,
Tasneam Shagroni, and Chantel Park, and Emilie Rouah, and Onome Whiteru
September 2016, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Tasneam Shagroni, and Chantel Park, and Emilie Rouah, and Onome Whiteru
January 2020, Therapeutics and clinical risk management,
Tasneam Shagroni, and Chantel Park, and Emilie Rouah, and Onome Whiteru
January 2017, Clinical medicine insights. Case reports,
Tasneam Shagroni, and Chantel Park, and Emilie Rouah, and Onome Whiteru
February 2021, Cureus,
Tasneam Shagroni, and Chantel Park, and Emilie Rouah, and Onome Whiteru
April 2023, Journal of pharmacy practice,
Tasneam Shagroni, and Chantel Park, and Emilie Rouah, and Onome Whiteru
October 2013, Muscle & nerve,
Tasneam Shagroni, and Chantel Park, and Emilie Rouah, and Onome Whiteru
May 2021, Clinical case reports,
Copied contents to your clipboard!